All studies
RecruitingHuman Pharmacology (Phase I)- OtherInterventional

Effect of nucleoside reverse transcriptase inhibitors on innate immune priming

The immune system has two main parts. The innate immune system is your body's rapid first line of defence against germs. Scientists have recently found that these defence cells can be 'trained' or primed to respond more effectively when they encounter threats. This early-stage (Phase 1) clinical trial looks at a group of medicines called nucleoside reverse transcriptase inhibitors. These medications are widely used to treat viruses such as HIV, but doctors believe they may also have an unexpected benefit: helping to wake up and strengthen innate immune cells. Researchers are testing this idea in healthy adult men. Participants will receive the study medication and attend clinic visits so doctors can check their blood and see how their immune cells respond. While this trial does not aim to cure a disease today, it could help scientists design new ways to boost immunity against infections in the future.

At a glance

Status
Recruiting
Phase
Human Pharmacology (Phase I)- Other
Sponsor
Rheinische Friedrich-Wilhelms-Universitaet Bonn
Enrolment target
12
Start
08 May 2024

What is this study about?

Our bodies have a built-in security network known as the innate immune system. It acts quickly to fight off everyday bugs and viruses before they can make us unwell. For a long time, medical experts believed that this part of the immune system responded in the exact same way every time it met a germ. However, newer research shows that innate immune cells can actually be 'primed'—meaning they can be trained to become more alert and effective.

This study looks at medications known as nucleoside reverse transcriptase inhibitors (often shortened to NRTIs). These are established medicines that doctors commonly prescribe to stop certain viruses from multiplying. Scientists now suspect that these drugs might also act as a trigger for innate immune cells, encouraging them to enter a stronger, ready-to-defend state.

Because this is a Phase 1 pharmacology trial, the main goal is to understand how the medicine behaves inside the human body and how it influences immune cells in a controlled setting. The findings from this research will provide valuable biological clues that could help doctors develop new therapies to protect vulnerable people from serious illnesses in the years ahead.

Key takeaways

  • This Phase 1 study looks at how antiviral medicines affect the body's natural immune defence system.
  • The trial is open to healthy men aged 18 and older.
  • Participation involves taking the study medication, attending clinic visits, and having blood tests.
  • There is no direct medical benefit, but the research helps scientists understand how to train the immune system.
  • Joining is entirely voluntary, and you are free to leave the trial at any point.

Who may be eligible?

This study is open to healthy men aged 18 and older. Because this is an early-stage study exploring how the medicine affects normal body processes, participants must be in generally good health and free from major long-term illnesses.

Women are not eligible to join this particular trial. In early pharmacology studies, researchers often focus on a single sex to keep the group as uniform as possible and to prevent any potential risks to reproductive health or pregnancy.

Before taking part, volunteers will have a health check that includes blood tests and basic physical checks. This ensures it is safe for you to take part and confirms that your liver, kidneys, and immune system are working normally.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am a man aged 18 or older.
  2. I consider myself to be in good general health.
  3. I do not have any long-term medical conditions or chronic diseases.
  4. I am not currently taking regular prescription medicines.
  5. I am comfortable attending clinic appointments and having routine blood tests.
Answer every question to see your result.

What does participation involve?

If you take part, you will be invited to a clinical research unit for an initial screening visit. The study team will explain everything in detail, answer any questions, and carry out routine health checks. If you are eligible and choose to join, you will be given the study medication to take. Over the course of the study—which typically lasts from a few days to several weeks—you will attend scheduled clinic visits. During these visits, doctors will monitor your health, check for any side effects, and take small blood samples to examine how your immune cells are reacting. You will have a final check-up at the end of the trial to ensure you remain well.

Potential risks and benefits

Because you are joining as a healthy volunteer, there is no direct personal medical benefit to taking part, although you will receive a comprehensive health check. Your participation will help scientists learn more about how to strengthen human immunity. Like all medications, there is a chance of experiencing side effects, which may include mild symptoms such as an upset stomach, headache, or tiredness, as well as minor bruising from blood tests. You will be monitored closely by medical staff throughout the trial. Taking part is completely voluntary, and you are free to leave the study at any time without having to give a reason.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Germany

Common questions

Do I need to be ill to take part in this study?

No. This study is specifically looking for healthy volunteers with no long-term illnesses or active infections.

Why is this trial only open to men?

Early Phase 1 studies often focus on one sex to keep test results consistent and avoid any unknown risks to pregnancy or fertility. Future trials may include women.

Are the study medications completely new?

The type of medication being tested is already well known and used in medicine, but researchers are studying a completely new way it might interact with your immune cells.

Will I be compensated for my time?

Many clinical trials for healthy volunteers offer payment to cover travel expenses and time spent at the clinic. The study team will explain any compensation before you decide to take part.

What happens if I change my mind during the trial?

You can leave the trial at any point. Deciding to withdraw will never affect your regular NHS healthcare or relationship with your doctor.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Effect of nucleoside reverse transcriptase inhibitors on inn…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.